Analystreport

Pacira Biosciences Inc (NASDAQ: PCRX) was given a new $46.00 price target on by analysts at BMO Capital Markets. They now have a "hold" rating on the stock.

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com